David Rawlings is Scientific Co-founder, Senior Scientific Advisor for GentiBio and member of its Scientific Advisory Board. He is also the Director of the Center for Immunity and Immunotherapies at Seattle Children’s Research Institute and Chief of the Division of Immunology overseeing the immunodeficiency clinical program at Seattle Children’s Hospital. David is a Professor of Pediatrics and Immunology at the University of Washington and previously held faculty appointments at UCLA. He has received numerous awards including the Seattle Children’s Guild Association Endowed Chair in Pediatric Immunology, Tom Hansen Investigator in Pediatric Innovation Endowment, and election to the American Society for Clinical Investigation and Association of American Physicians. David received a B.S. in Biological Sciences, Magna Cum Laude from Davidson College and received his M.D. from the University of North Carolina.
David Rawlings, MD
Director, Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Scientific Co-founder and Senior Scientific Advisor